InvestorsHub Logo
Followers 3181
Posts 208744
Boards Moderated 2
Alias Born 02/04/2004

Re: doogdilinger post# 32371

Wednesday, 01/24/2018 8:41:31 AM

Wednesday, January 24, 2018 8:41:31 AM

Post# of 38634

In addition, the Company continues efforts to identify opportunities overseas, including in China, that could if effectuated provide product distribution alternatives through partnerships and therefore do not require an investment or asset acquisition by the Company.  The Company recently visited China where discussions toward establishing a partnership to facilitate future development activities are ongoing.  The Company has not entered into any such arrangements at this time.  These opportunities could involve out-licensing of our products, third-party manufacturing supply and more efficient access to pharmaceutical ingredients and therefore assist with the development of our growing product pipeline.



Not quite the detail/clarity we were hoping for on the recent China maneuvering...but I do think it's a clear indication that more news on exactly what that photo-op and contract signing between Smart Pharma(manufacturers) and Shanghai Pharma(distributors) actually entails may soon be forthcoming...at least that's what logic strongly suggests glta


Never buy or sell based on my posts! My posts are just my opinion!